Cargando…
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
We tested the ability of a novel DNA methylation biomarker set to distinguish metastatic pancreatic cancer cases from benign pancreatic cyst patients and to monitor tumor dynamics using quantitative DNA methylation analysis of cell-free DNA (cfDNA) from blood samples. The biomarkers were able to dis...
Autores principales: | Vrba, Lukas, Futscher, Bernard W., Oshiro, Marc, Watts, George S., Menashi, Emmanuel, Hu, Charles, Hammad, Hytham, Pennington, Daniel R., Golconda, Umamaheshwari, Gavini, Hemanth, Roe, Denise J., Shroff, Rachna T., Nelson, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864826/ https://www.ncbi.nlm.nih.gov/pubmed/35193708 http://dx.doi.org/10.1186/s13148-022-01246-2 |
Ejemplares similares
-
Gastric heterotopia with perforation mimicking neoplastic process in ileum
por: Carlson, Quinlan, et al.
Publicado: (2020) -
Do Pentraxins Bind to Fungi in Invasive Human Gastrointestinal Candidiasis?
por: Golconda, Umamaheshwari, et al.
Publicado: (2018) -
Cyst fluid metabolites distinguish malignant from benign pancreatic cysts
por: Shi, Jiaqi, et al.
Publicado: (2021) -
DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients
por: Vrba, Lukas, et al.
Publicado: (2019) -
Liquid biopsies to distinguish malignant from benign pulmonary nodules
por: Tao, Rui, et al.
Publicado: (2021)